Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6651–6700 of 18417
Effective January 22, 2024, B. Bradford Martz, President, will step down from his role of Chief Financial Officer to focus on his position as President of American Coastal Insurance Corporation
The Company has appointed Svetlana Castle, JD, MPA, CPA, as the Company's new Chief Financial Officer effective January 22, 2024.
Lori Radcliffe resigned from her position as Chief Financial Officer on November 30, 2023.
He succeeds Robert Clark, who resigned from the Company and the Board on November, 30, 2023, to pursue other interests.
appointed Jermain Strong to the position of Chief Executive Officer and Director, effective immediately.
Haiping Hu, the Company’s Chief Executive Officer, Chief Financial Officer, Secretary, and sole director, has tendered his resignation from all of his officer positions with the Company and as the sole director, which resignation will become effective ten days after the mailing of the Schedule 14f-1 (the “Effective Date”) filed with the SEC and mailed on January 18, 2024.
Shitong Li was appointed by the Board of Directors of the Company (the “Board”) as Chief Executive Officer, Chief Financial Officer and Secretary of the Company, effective as of the Effective Date.
Greg Martyr as Chief Executive Officer and director
Weiyi Zheng as Chief Executive Officer and Chairman of the Board
Kris Salinger as Chief Financial Officer and director
On January 15, 2024, Julie Andrews began service as Chief Financial Officer of Orthofix Medical Inc.
appointed Todd P. Branning, who has served as the Company’s Chief Financial Officer since January 2022, as the Company’s interim Chief Executive Officer
terminated the employment of Dietrich A. Stephan, Ph.D. as Chief Executive Officer of the Company, without cause
announced the promotion and appointment of Nick Barzee to become Senior Vice President and Chief Financial Officer of the Company and the Bank, effective on August 1, 2024.
announced the retirement of Michelle Plummer, Senior Executive Vice President, Chief Financial Officer and Chief Operating Officer of the Company and the Bank. The retirement is effective July 31, 2024.
Mr. Irby was released from his role after a prolonged absence.
On January 15, 2024, Ms Hernandez was appointed as Chief Financial Officer and Executive Vice President to succeed Denis Irby.
the Company terminated the employment of each of Gail McIntrye, Ph.D., the Company’s Chief Executive Officer and Rudy C. Howard, the Company’s Chief Financial Officer, effective as of January 17, 2024.
the Company terminated the employment of each of Gail McIntrye, Ph.D., the Company’s Chief Executive Officer and Rudy C. Howard, the Company’s Chief Financial Officer, effective as of January 17, 2024.
as of the Employment Date, Mr. Spruill will depart from the Company.
On January 11, 2024, DigitalOcean Holdings, Inc. (the “Company”) entered into an employment agreement with Padmanabhan Srinivasan (the “Srinivasan Agreement”) to serve as Chief Executive Officer of the Company, effective as of the commencement of his employment, which is currently expected to be on or around February 12, 2024 (the “Employment Date”).
On January 16, 2024, the Board of Directors of Foghorn Therapeutics Inc. (the “Company”) appointed Stephen J. DiPalma as Treasurer and interim Chief Financial Officer (“CFO”), effective immediately.
On January 10, 2024, the Board of Directors of the Company (the “Board”) appointed Naiem Hussain, 56, the Company’s current Chief Investment Officer, to serve as Chief Financial Officer of the Company, pending the completion of the Company’s hiring protocols.
Ms. Dybeck Happe gave notice of her departure from GE effective February 14, 2024 due to her resignation for "Good Reason" as a result of the CFO transition.
On January 16, 2024, the Company announced that Marc Vandiepenbeeck, the Company’s current Vice President and President, Building Solutions, Europe, Middle East, Africa and Latin America, will succeed Mr. Leonetti as the Company’s Executive Vice President and Chief Financial Officer and principal financial officer.
On January 9, 2024, Olivier Leonetti notified Johnson Controls International plc (the “Company”) of his intention to resign as the Company’s Executive Vice President and Chief Financial Officer and principal financial officer to take an executive role outside of the Company.
Mr. Horwath will succeed Allen Muhich, who will cease serving and depart as Chief Financial Officer effective as of the Effective Date.
The Company also announced that Dalip M. Puri was elected Executive Vice President and Chief Financial Officer of the Company effective April 2, 2024, assuming Mr. Burke’s position.
On January 16, 2024, AMETEK, Inc. (the “Company”) announced that William J. Burke, Executive Vice President and Chief Financial Officer, intends to retire effective April 2, 2024.
Robert Michael Dudley entered into a separation agreement with the Company pursuant to which he resigned from his position as the Company’s President and Chief Executive Officer, and as a director of the Company, in each case effective January 13, 2024.
Thomas A. Fitzgerald, the Company’s Chief Financial Officer, was appointed to serve as the Company’s Interim President and Chief Executive Officer, effective January 13, 2024.
Mr. Crutchfield will cease to serve as President, Chief Executive Officer and as a member of the Board, effective January 17, 2024.
the Board appointed Edward C. Dowling, Jr. as the Company’s President and Chief Executive Officer, effective January 18, 2024
Yaron Garmazi, Chief Financial Officer of Kaltura, Inc. (the “ Company ”), notified the Company of his intention to resign from this position, effective February 29, 2024.
the Board of Directors (the “ Board ”) of the Company appointed John Doherty as Chief Financial Officer of the Company, effective March 1, 2024
On April 24, 2023, Ryvyl appointed Ben Errez, Ezra Laniado, and Genevieve Baer to the Board of Directors, and the directors proceeded to appoint Ben Errez and Jasmine Farrington as Chief Executive Officer and Secretary, respectively.
The Chief Financial Officer and Principal Accounting Officer of the Company, Cheng Yew Siong, likewise resigned making the same representation as Mr. Han regarding no disagreements with the Company.
On January 12, 2024, the Company’s Board of Directors appointed Jason Krantz, the Company’s founder and Executive Chairman, as Interim Chief Executive Officer, effective January 16, 2024.
On January 16, 2024, the Company announced that Robert Musslewhite has stepped down as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors, effective January 16, 2024
On January 11, 2024, the Board of Directors of Mirum Pharmaceuticals, Inc. (the “Company”) promoted Peter Radovich, previously the Company’s Chief Operating Officer, to the additional position of President, with Christopher Peetz, who previously served as the Company’s President and Chief Executive Officer, continuing to serve as the Company’s Chief Executive Officer, each effective as of January 16, 2024.
Joseph Frattaroli provided notice to the Board of Directors (the “Board”) of Inhibikase Therapeutics, Inc. (the “Company”) of his intention to retire as Chief Financial Officer of the Company, effective at the end of the first quarter of 2024 or March 31, 2024.
The Board will appoint Garth Lees-Rolfe to serve as Chief Financial Officer of the Company upon Mr. Frattaroli’s retirement and until the earliest of his removal, termination, or resignation from such office.
the Company announced that the board of directors (the “Board”) of the Company appointed Mallorie Burak as the Company’s Chief Financial Officer, effective as of the Effective Date.
Effective as of January 15, 2024 (the “Effective Date”), Susan Kim van-Dongen no longer serves as Interim Chief Financial Officer of Energous Corporation (the “Company”).
On January 11, 2024, Kiki Benson, the CFO of the Company, resigned as CFO, effective immediately.
On January 11, 2024, the Board of Directors of the Company appointed Mark J. Keeley as Chief Financial Officer of the Company on a consultancy basis.
On January 15, 2024 (the “Separation Date”), Andrei Floroiu resigned (i) as President and Chief Executive Officer of the Company, and (ii) as a member of the Company’s Board of Directors
On January 16, 2024, the Board announced that, effective as of January 16, 2024, the current Chair of the Board, Michael J. Finney, Ph.D, has been appointed as Interim Chief Executive Officer of the Company.
On January 10, 2024, Chris Coulter resigned as the Company’s Chief Financial Officer.
On January 10, 2024, John Dalfonsi resigned as a member of the Company’s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, and was appointed to serve as the Company’s Chief Financial Officer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.